• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症肌无力合并格雷夫斯病:一例报告。

Myasthenia gravis complicated by Graves' disease: a case report.

作者信息

Kamabu Larrey Kasereka, Oboth Ronald, Kataka Louange Maha, Baruani Albert Yemba, Lekuya Hervé Monka, Kangitsi Charles Kahindo

机构信息

Faculty of Medicine, Neurosurgery Division, Catholic University of Graben, P.O. Box 29, Butembo, Democratic Republic of the Congo.

Department of Surgery, Neurosurgery, College of Medicine, Makerere University, Kampala, Uganda.

出版信息

J Med Case Rep. 2025 Jul 29;19(1):375. doi: 10.1186/s13256-025-05198-y.

DOI:10.1186/s13256-025-05198-y
PMID:40734191
Abstract

INTRODUCTION

Myasthenia gravis is a neuromuscular autoimmune condition characterized by the presence of antibodies against acetylcholine receptors. It may present as a generalized disorder or remain limited to specific muscle groups. Myasthenia gravis can occur independently or alongside other autoimmune conditions, including Hashimoto's thyroiditis and Graves' disease. Although the co-occurrence of these disorders is recognized, it is an extremely rare clinical phenomenon.

CASE PRESENTATION

A 20-year-old woman of Muganda ethnicity, with a 2-year history of Graves' disease confirmed by thyroid scintigraphy, developed a myasthenic syndrome leading to acute respiratory failure. Her condition improved with the administration of Prostigmine. Further investigations, including electrophysiological studies and immunological tests, confirmed a diagnosis of myasthenia gravis. The patient demonstrated a positive response to medical therapy.

CONCLUSION

This case highlights the importance of recognizing the rare association between myasthenia gravis and Graves' disease. Accurate diagnosis and effective treatment require a coordinated, multidisciplinary approach, particularly given the challenges posed by overlapping symptoms and the exacerbating effects of hyperthyroidism on myasthenia gravis.

摘要

引言

重症肌无力是一种神经肌肉自身免疫性疾病,其特征是存在抗乙酰胆碱受体抗体。它可能表现为全身性疾病,也可能局限于特定肌肉群。重症肌无力可独立发生,也可与其他自身免疫性疾病同时出现,包括桥本甲状腺炎和格雷夫斯病。尽管这些疾病的共现已得到认可,但这是一种极其罕见的临床现象。

病例介绍

一名20岁的穆干达族女性,经甲状腺闪烁扫描确诊患有格雷夫斯病2年,出现了导致急性呼吸衰竭的重症肌无力综合征。使用新斯的明治疗后病情好转。进一步检查,包括电生理研究和免疫学检测,确诊为重症肌无力。该患者对药物治疗表现出积极反应。

结论

本病例凸显了认识重症肌无力与格雷夫斯病之间罕见关联的重要性。准确的诊断和有效的治疗需要一种协调的多学科方法,特别是考虑到重叠症状带来的挑战以及甲状腺功能亢进对重症肌无力的加重作用。

相似文献

1
Myasthenia gravis complicated by Graves' disease: a case report.重症肌无力合并格雷夫斯病:一例报告。
J Med Case Rep. 2025 Jul 29;19(1):375. doi: 10.1186/s13256-025-05198-y.
2
Multi-disciplinary collaboration in diagnosing thymic hyperplasia in a Graves' disease patient.多学科协作诊断一名格雷夫斯病患者的胸腺增生
Endocrinol Diabetes Metab Case Rep. 2025 Apr 8;2025(2). doi: 10.1530/EDM-24-0125. Print 2025 Apr 1.
3
Hickam's dictum: Myasthenia Gravis presenting concurrently with Graves' disease.希卡姆格言:重症肌无力与格雷夫斯病同时出现。
BMJ Case Rep. 2017 Sep 7;2017:bcr-2017-220153. doi: 10.1136/bcr-2017-220153.
4
Case Report: Therapeutic effect of efgartigimod in refractory anti-GQ1b antibody syndrome coexisting with myasthenia gravis.病例报告:艾加莫德治疗难治性抗GQ1b抗体综合征合并重症肌无力的疗效
Front Immunol. 2025 Jun 10;16:1605985. doi: 10.3389/fimmu.2025.1605985. eCollection 2025.
5
Acetylcholinesterase inhibitor treatment for myasthenia gravis.重症肌无力的乙酰胆碱酯酶抑制剂治疗
Cochrane Database Syst Rev. 2014 Oct 13;2014(10):CD006986. doi: 10.1002/14651858.CD006986.pub3.
6
Medical and surgical treatment for ocular myasthenia.眼肌型重症肌无力的药物及手术治疗
Cochrane Database Syst Rev. 2006 Apr 19(2):CD005081. doi: 10.1002/14651858.CD005081.pub2.
7
Thyroid surgery for Graves' disease and Graves' ophthalmopathy.用于治疗格雷夫斯病和格雷夫斯眼病的甲状腺手术。
Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD010576. doi: 10.1002/14651858.CD010576.pub2.
8
Differential Scanning Calorimetry as a Monitoring Tool for the Effectiveness of Therapeutic Plasma Exchange in Anti-AChR Myasthenia Gravis, Anti-MuSK Myasthenia Gravis, and Myasthenic Syndrome: A Case Series.差示扫描量热法作为监测抗乙酰胆碱受体重症肌无力、抗肌肉特异性激酶重症肌无力和肌无力综合征治疗性血浆置换疗效的工具:病例系列
J Clin Med. 2025 Jul 14;14(14):4968. doi: 10.3390/jcm14144968.
9
Starting eculizumab as rescue therapy in refractory myasthenic crisis.开始使用依库珠单抗作为难治性肌无力危象的抢救治疗。
Neurol Sci. 2023 Oct;44(10):3707-3709. doi: 10.1007/s10072-023-06900-y. Epub 2023 Jun 12.
10
Myasthenia gravis in conjunction with Graves' disease: a diagnostic challenge.重症肌无力合并格雷夫斯病:诊断难题
Endocr Pract. 2001 Jul-Aug;7(4):275-8. doi: 10.4158/EP.7.4.275.

本文引用的文献

1
The genetics of Graves' disease.格雷夫斯病的遗传学。
Rev Endocr Metab Disord. 2024 Feb;25(1):203-214. doi: 10.1007/s11154-023-09848-8. Epub 2023 Dec 18.
2
Molecular Mechanisms in Autoimmune Thyroid Disease.自身免疫性甲状腺疾病的分子机制。
Cells. 2023 Mar 16;12(6):918. doi: 10.3390/cells12060918.
3
Inflammation and autoimmune myasthenia gravis.炎症与自身免疫性重症肌无力。
Front Immunol. 2023 Jan 30;14:1110499. doi: 10.3389/fimmu.2023.1110499. eCollection 2023.
4
Myasthenia gravis in clinical practice.临床实践中的重症肌无力。
Arq Neuropsiquiatr. 2022 May;80(5 Suppl 1):257-265. doi: 10.1590/0004-282X-ANP-2022-S105.
5
Management of Graves' hyperthyroidism: present and future.格雷夫斯病甲亢的管理:现状与未来。
Expert Rev Endocrinol Metab. 2022 Mar;17(2):153-166. doi: 10.1080/17446651.2022.2052044. Epub 2022 Mar 14.
6
Dual attack: targeting the rare co-occurrence of myasthenia gravis and Graves' disease with radioactive iodine therapy.双重攻击:用放射性碘疗法针对重症肌无力和格雷夫斯病罕见的共同出现情况进行治疗
Endocrinol Diabetes Metab Case Rep. 2021 Jul 1;2021. doi: 10.1530/EDM-21-0046.
7
Myasthenia Gravis and its Association With Thyroid Diseases.重症肌无力及其与甲状腺疾病的关联。
Cureus. 2020 Sep 4;12(9):e10248. doi: 10.7759/cureus.10248.
8
Generalized Myasthenia Gravis: Classification, Clinical Presentation, Natural History, and Epidemiology.全身型重症肌无力:分类、临床表现、自然史及流行病学
Neurol Clin. 2018 May;36(2):253-260. doi: 10.1016/j.ncl.2018.01.002.
9
Developing treatment guidelines for myasthenia gravis.制定重症肌无力治疗指南。
Ann N Y Acad Sci. 2018 Jan;1412(1):95-101. doi: 10.1111/nyas.13537.
10
Myasthenia gravis: new developments in research and treatment.重症肌无力:研究与治疗的新进展
Curr Opin Neurol. 2017 Oct;30(5):464-470. doi: 10.1097/WCO.0000000000000473.